Supplementary figure characterizes CD155 expression in primary NSCLC patients, implying its role in immune response modulation.
Supplementary Figure 6 shows the characterization of CD155 expression in surgically resected primary NSCLC patients.
No takes yet. Share an insight, caveat, or question.
Thomas-Jardin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: